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Materials and Methods
Reagents Human obestatin, nonamidated obestatin (NA-obestatin), and (des1-10)obestatin were synthesized by GL Biochem Ltd. (Shanghai, China) and purified by reverse phase highperformance liquid chromatography. The peptide sequences were verified by amino acid analysis and mass spectrometry. Ghrelin, motilin, neurotensin, neuromedin U, and MTII were purchased from Phoenix Pharmaceuticals (Belmont, CA). The rabbit polyclonal antibodies against synthetic human obestatin peptide were produced by Quality Controlled Biochemicals (Hopkinton, MA).
Immunoassays for obestatin, ghrelin, and leptin Tissue extracts and sera were used for the measurement of obestatin and ghrelin immunoreactivities. Immuno-obestatin was determined using rabbit polyclonal antibodies at a final dilution of 1:6,000. The reaction mixture consisted of 100 µl of test samples or standards together with 100 µl of the antiserum. Samples were incubated for 24 hours at 4 °C, 100 µl of tracer (10,000-15,000 cpm) was added, and the samples further incubated for another 24 hours at 4 °C. Free and bound obestatin were separated by the solid phase second antibody method using donkey anti-rabbit IgG (Phoenix Pharmaceuticals) before counting in a γ-spectrometer (LKB, Uppsala, Sweden). Total (n-octanoyl and des-acyl) ghrelin immunoreactivity was determined using a specific radioimmunoassay (Phoenix Pharmaceuticals). No cross-reactivity was found between the obestatin and ghrelin radioimmunoassays. Circulating ghrelin and obestatin levels were measured in adult male Sprague-Dawley rats before and after fasting for 48 hours, or fasting followed by free access to food or drinking water containing 50% dextrose for 2 hours. Following long term treatment with obestatin, serum leptin levels were determined using an enzyme-linked immunosorbent assay (Phoenix Pharmaceuticals).
Purification of obestatin Stomach preparations (67 g) from 30 rats were minced and boiled for 5 min. in 5 volumes of water to inactivate intrinsic proteases. Before homogenization with a Polytron mixer, the solution was adjusted to 1 M acetic acid and 20 mM HCl. After centrifugation at 225,000 g for 30 min., the supernatant was concentrated to 100 ml using an evaporator before precipitation under 66% acetone. After removal of the precipitates, the volume 1 of the supernatant was reduced by acetone evaporation before loading onto a 10-g cartridge of Sep-Pak C18 (Waters, Milford, MA) pre-equilibrated with 0.1% trifluoroacetic acid (TFA). The Sep-Pak cartridge was washed with 10% acetonitrile/0.1% TFA, and then eluted with 60% acetonitrile/0.1% TFA. Peptides in the eluate were lyophilized, dissolved in 1 M acetic acid, and fractionated using a Sephadex G-50 gel filtration column. A portion of each fraction was used for obestatin and ghrelin radioimmunoassays. Fractions containing immuno-obestatin were further separated by ion-exchange FPLC on a UNO Q1 column (BioRad) at pH 8.1. After identification of the peak containing immuno-obestatin, the samples were subjected to mass spectrometry and de novo N-terminal sequencing at Pan Facility (Stanford University, CA). Pituitary cell cultures Anterior pituitaries were removed from adult male Sprague-Dawley rats and dispersed with 0.3% collagenase, 0.1% hyaluronidase and DNase I (10 µg/ml). The cell suspension was centrifuged at 300 g for 5 min. and cells were washed twice before incubation in Dulbecco minimal essential medium (DMEM) containing 0.1% bovine serum albumin (BSA), penicillin (100 units/ml), streptomycin (100 µg/ml), fungizone (2.5 µg/ml), and 10% fetal calf serum. Cells were seeded onto poly-lysine-coated 24-well plates at a density of ~3×10 5 cells/well.
Labeling of obestatin and receptor binding
Cultures were kept in a humidified atmosphere of 5% CO 2 and 95% air at 37°C. After a 72 h- 
